<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap8" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>8</ChapterID>
            <ChapterNumber>8</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_8</ChapterDOI>
            <ChapterSequenceNumber>8</ChapterSequenceNumber>
            <ChapterTitle Language="En">Human Mesenchymal Stem Cell Culture for Neural Transplantation</ChapterTitle>
            <ChapterFirstPage>103</ChapterFirstPage>
            <ChapterLastPage>118</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_8" CorrespondingAffiliationID="Aff1_8">
                <AuthorName DisplayOrder="Western">
                  <GivenName>David</GivenName>
                  <FamilyName>Gordon</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff2_8" CorrespondingAffiliationID="Aff2_8">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Neil</GivenName>
                  <GivenName>J.</GivenName>
                  <FamilyName>Scolding</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>n.j.scolding@bristol.ac.uk</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_8">
                <OrgDivision>University of Bristol Institute of Clinical Neurosciences</OrgDivision>
                <OrgName>Frenchay Hospital</OrgName>
                <OrgAddress>
                  <State>Bristol</State>
                  <Country>UK</Country>
                </OrgAddress>
              </Affiliation>
              <Affiliation ID="Aff2_8">
                <OrgDivision>Glial Cell Biology Laboratories, Institute of Clinical Neurosciences, Frenchay Hospital</OrgDivision>
                <OrgName>University of Bristol</OrgName>
                <OrgAddress>
                  <Postcode>BS16 1LE</Postcode>
                  <City>Bristol</City>
                  <Country>UK</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_8" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>Mesenchymal stem cells (MSCs) have the potential to play a role in autologous repair of central nervous system injury or disease, circumventing both the complications associated with immune rejection of allogenic cells, and many of the ethical concerns associated with embryonic stem cell use. Human bone marrow-derived MSCs can be extracted relatively simply from the marrow of adult patients and maintained and expanded in culture. More importantly, it has been previously demonstrated that MSCs have the capacity to differentiate into neurons and glia in vitro when grown under appropriate conditions. Multipotent MSCs have also been successfully used in transplantation studies in animal models of disease as diverse as demyelination, stroke, trauma and Parkinson’s disease. MSCs therefore provide an attractive and practical source of stem cells for reparative therapy in patients, and in this paper we describe methods for the reproducible culture and neural differentiation of human MSCs generated from patient marrow.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Key words</Heading>
              <Keyword>Culture</Keyword>
              <Keyword>Neural differentiation</Keyword>
              <Keyword>Human mesenchymal stem cells</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_8">
              <Heading>Introduction</Heading>
              <Para>Stem cells have enormous potential as therapeutic tools in the treatment of neurological diseases as diverse as multiple sclerosis (MS), stroke, trauma and Parkinson’s disease (<CitationRef CitationID="CR1_8">1</CitationRef>–<CitationRef CitationID="CR4_8">4</CitationRef>). Most studies have focused on the use of embryonic tissue as the primary stem cell source, but this raises significant practical, immunological and ethical concerns. It is now well accepted that adult stem cells are present in a variety of different tissue types and that these tissue-specific cells have the capacity to differentiate into a wider range of cell types than previously thought (<CitationRef CitationID="CR5_8">5</CitationRef>–<CitationRef CitationID="CR8_8">8</CitationRef>). The multipotentiality of adult stem cells has generated much interest in their use as autologous treatments for neurological disease, since it provides a way to circumvent many of the difficulties arising from the use of embryonic stem cells (<CitationRef CitationID="CR5_8">5</CitationRef>, <CitationRef CitationID="CR6_8">6</CitationRef>, <CitationRef CitationID="CR9_8">9</CitationRef>, <CitationRef CitationID="CR10_8">10</CitationRef>).</Para>
              <Para>An attractive source of adult stem cells for autologous stem cell replacement therapies in the central nervous system (CNS) is bone marrow (<CitationRef CitationID="CR11_8">11</CitationRef>–<CitationRef CitationID="CR14_8">14</CitationRef>). Human bone marrow-derived mesenchymal stem cells (MSCs) can be extracted relatively simply from adult tissue and maintained in cell culture. When cultured under the appropriate conditions MSCs are able to generate cells specific to the mesenchymal lineage in vitro, specifically chondrocytes (cartilage), osteoblasts (bone) and adipocytes (fat) (<CitationRef CitationID="CR12_8">12</CitationRef>, <CitationRef CitationID="CR14_8">14</CitationRef>). It has further been demonstrated that both human and rodent MSCs display remarkable phenotypic plasticity, <Emphasis Type="Italic">trans</Emphasis>-differentiating into neural cells in vitro in the presence of appropriate growth factors (<CitationRef CitationID="CR15_8">15</CitationRef>–<CitationRef CitationID="CR18_8">18</CitationRef>). More recently it has been shown that human MSCs cultured in the presence of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) can be induced to grow as neural stem cell (NSC)-like neurospheres in vitro (<CitationRef CitationID="CR19_8">19</CitationRef>). The cells within these neurosphere-like structures express high levels of early neuroectodermal markers, such as the proneural genes and nestin (<CitationRef CitationID="CR19_8">19</CitationRef>).</Para>
              <Para>Such studies have provided the impetus for a range of experimental investigations exploring the potential reparative or neuroprotective effects of MSCs in models of neurological or neurodegenerative disease (<CitationRef CitationID="CR20_8">20</CitationRef>–<CitationRef CitationID="CR23_8">23</CitationRef>). MSCs therefore represent an attractive clinical option for developing cell therapies for disease treatment. However, if such studies successfully lead to future translational studies in patients, then human rather than rodent cells must be investigated, and in this paper we describe practical methods for the culture and differentiation of such human MSCs.</Para>
            </Section1>
            <Section1 ID="Sec2_8">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_8">
                <Heading>General Lab and Cell Culture
Equipment</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Class 2 biological safety cabinet or laminar-flow hood.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Vacuum pump and trap containing disinfectant.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Inverted light microscope with phase contrast optics for checking cells and cell counts.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Falcon-style 15-ml and 50-ml tubes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Plastic Petri-dishes and disposable scalpels.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Sterile disposable glass Pasteur pipettes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Sterile disposable plastic Pasteur pipettes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Haemocytometer and Trypan blue solution (Sigma-Aldrich) for cell counts.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Cell culture incubators set at 37°C and 5% CO<Subscript>2</Subscript> in air, and able to maintain &gt;95% humidity.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Bench top, low speed centrifuge with an option to enable slow deceleration. Buckets that can accommodate 15-ml and 50-ml tubes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>Water-bath set at 37°C.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>12.</ItemNumber>
                      <ItemContent>
                        <Para>P2, P20, P200, P1000 Gilson Pipetman pipettes or equivalent.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec4_8">
                <Heading>Human MSC Culture</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>RPMI-1640 + 10% heparin. Add 5 ml of heparin solution to 45 ml of RPMI-1640 to give a final concentration of 100 U heparin/ml. Ten milliliters are sufficient in a sterile 50-ml tube for marrow collection.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Hanks’ balanced salt solution (HBSS).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Ficoll.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Red blood cell lysis buffer. Add 4.15 g ammonium chloride (NH<Subscript>4</Subscript>CL), 0.5 g potassium bicarbonate (KHCO<Subscript>3</Subscript>) and 0.02 g EDTA to 500 ml of distilled H<Subscript>2</Subscript>O. Mix and filter sterilise. Can be frozen for long-term storage.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Dulbecco’s modified Eagles medium (DMEM). Add 10 g of DMEM powder and 3.7 g of sodium bicarbonate (NaHCO<Subscript>3</Subscript>) to 1 L of distilled H<Subscript>2</Subscript>O. Mix, pH to 7.2 and filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Phosphate buffered saline (PBS), pH 7.4. Autoclave or filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Foetal bovine serum (FBS).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Recombinant human basic fibroblast growth factor (rh bFGF). Store as 25 μg/ml stocks made up in PBS + 1% FBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>25-cm<Superscript>2</Superscript>, 75-cm<Superscript>2</Superscript> and 175-cm<Superscript>2</Superscript> tissue culture flasks.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Trypsin/EDTA solution.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>Accutase (Chemicon).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>12.</ItemNumber>
                      <ItemContent>
                        <Para>FBS for human MSCs (Stem cell technologies).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>13.</ItemNumber>
                      <ItemContent>
                        <Para>MSC growth medium. 50 ml of FBS for human MSCs, 10 ml of penicillin/streptomycin solution, 2.5 ml of a 200 mM solution of <Emphasis Type="SmallCaps">l</Emphasis>-glutamine and 10 μl of a 25 μg/ml stock of rh bFGF (1 ng/ml final concentration) in 437.5 ml of DMEM. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>14.</ItemNumber>
                      <ItemContent>
                        <Para>250-ml (Corning Incorporated) and 500-ml (Corning Incorporated) filter systems.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>15.</ItemNumber>
                      <ItemContent>
                        <Para>13-mm diameter round coverslips.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>16.</ItemNumber>
                      <ItemContent>
                        <Para>4-well and 24-well tissue culture plates.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>17.</ItemNumber>
                      <ItemContent>
                        <Para>Poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine. Mix with 50 ml of distilled H<Subscript>2</Subscript>O. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>18.</ItemNumber>
                      <ItemContent>
                        <Para>Paraformaldehyde. Dilute to a 4% solution in PBS.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec5_8">
                <Heading>Long-Term Storage of Human MSC Cultures</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Cryotubes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>MSC growth medium + 50% FBS. Add 25 ml of MSC growth medium and 25 ml of FBS. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>MSC growth medium + 20% DMSO. Add 40 ml of MSC growth medium and 10 ml of dimethyl sulphoxide (DMSO).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Isopropanol.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Cryo 1°C freezing container (Nalgene) containing isopropanol.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec6_8">
                <Heading>Confirming the Mesenchymal Origin of Human MSCs</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Propidium Iodide solution.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>FACS tubes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Adipogenic induction medium. Add 5 ml of FBS, 1 ml of penicillin/streptomycin solution, 25 μl of a 1 mM stock of 1-methyl-3-isobutylxanthine (final concentration of 0.5 μM), 50 μl of a 1 mM stock of dexamethasone (final concentration of 1 μM), 50 μl of a 10 mg/ml stock of insulin (final concentration of 10 μg/ml) and 0.179 g of indomethacin (final concentration of 100 μM) to 44 ml of DMEM. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Adipogenic maintenance medium. Add 5 ml of FBS, 1 ml of penicillin/streptomycin solution and 50 μl of a 10 mg/ml stock of insulin (final concentration of 10 μg/ml) to 44 ml of DMEM. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Osteogenic induction medium. Add 5 ml of FBS, 1 ml of penicillin/streptomycin solution, 250 μl of a 10 mM stock of ascorbic acid (final concentration of 0.05 mM), 5 μl of a 1 mM stock of dexamethasone (final concentration of 100 nM) and 0.108 g of glycerol 2-phosphate (final concentration of 10 mM) to 44 ml of DMEM. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Chondrogenic induction medium. Add 12.5 μl of a 2 μg/ml stock of recombinant human transforming growth factor-β3 (final concentration of 10 ng/l), 1 ml of penicillin/streptomycin solution, 3.5 μl of a 1 mM stock of dexamethasone (final concentration of 10<Superscript>−7</Superscript> M), 500 μl of a 10 mM stock of ascorbic acid (final concentration of 0.1 mM), 125 μl of a 10 mg/ml stock of insulin (final concentration of 25 μg/ml) and 0.0625 g of bovine serum albumin (BSA) (final concentration of 1.25 mg/ml) to 49 ml of DMEM. Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>0.5 M sucrose solution. Add 17.115 g of sucrose to 100 ml of PBS. Mix well.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>OCT.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec7_8">
                <Heading>The Neurogenic Capacity of Human MSCs</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Low attachment plates and flasks.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Recombinant human epidermal growth factor (rh EGF). Store as 2 mg/ml stocks made up in PBS + 0.1% BSA.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Neurosphere medium. Add 5 ml of N2 supplement (final concentration of 1%; Invitrogen), 10 ml of penicillin/streptomycin solution (Gibco), 5 ml of a 200 mM solution of <Emphasis Type="SmallCaps">l</Emphasis>-glutamine (final concentration of 2 mM), 1 ml of a 10 mg/ml stock of insulin (final concentration of 25 μg/ml), 5 μl of a 2 mg/ml stock of rh EGF (final concentration of 20 ng/ml; Sigma-Aldrich), 400 μl of a 25 μg/ml of rh bFGF (final concentration of 20 ng/ml; Sigma-Aldrich) and 100 μl of a 10 μg/ml stock of human leukaemia inhibitory factor (final concentration of 2 ng/ml; Sigma-Aldrich) to 480 ml of Neuromed-N (Euroclone, UK). Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Neural induction medium. Add 500 μl of FBS (final concentration of 1%), 2.5 ml of horse serum (final concentration of 1%), 10 μl of a 25 mM stock solution of retinoic acid (final concentration of 5 μM) and 500 μl of N2 supplement (final concentration of 1%) to 46.5 ml of Neurobasal medium (Gibco). To promote predominantly neuronal differentiation, add 50 μl of a 10 μg/ml stock of recombinant human brain derived neurotrophic factor (rh BDNF) (final concentration of 10 ng/ml; Peprotech, UK). To promote predominantly glial differentiation, add 50 μl of a 10 μg/ml stock of recombinant human platelet derived growth factor BB (rh PDGF-BB) (final concentration of 10 ng/ml; R and D systems). Filter sterilise.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec8_8">
                <Heading>Immunostaining</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Blocking solution. Add 2 ml of normal goat serum (final concentration of 4%) and 50 μl of Triton-X100 (final concentration of 0.1%) to 48 ml of PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>22 × 22 mm coverslip.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Vectashield containing DAPI.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec9_8">
              <Heading>Methods</Heading>
              <Section2 ID="Sec10_8">
                <Heading>Human MSC Culture</Heading>
                <Section3 ID="Sec11_8">
                  <Heading>Extraction of Human MSCs from Bone Marrow</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Human bone marrow is collected from the femoral neck of patients undergoing total or partial hip replacement. Marrow is placed into a sterile 50-ml tube containing RPMI-1640 containing 10% heparin solution to prevent clotting (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec29_8">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>The samples are left overnight at room temperature in the dark.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer the marrow sample from the collection tube to a Petri dish. Add a small volume of HBSS (approximately 5 ml) to prevent the sample drying out. Using sterile scalpels break up the marrow as finely as possible, and scrape marrow from the underlying bone.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>When satisfied that as much of the sample as possible has been collected, transfer the cell-containing HBSS to a fresh, sterile
50-ml tube. At this stage, the homogenised cell suspension will appear as thick slurry, and may contain small particles of bone and debris. It is easiest to transfer the solution with a 10-ml disposable serological pipette. Rinse the Petri dish 2–3 times with HBSS to collect cells, and transfer this also to the sterile 50-ml tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Bring the total volume of the cell suspension up to 50 ml with HBSS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>For every 25 ml of diluted cell suspension, layer this over 25 ml of Ficoll in fresh 50-ml tubes. To prevent mixing at the solution interface, the tube should be held at a 45° angle and cells added by gently running the suspension along the inside wall of the tube using a disposable plastic Pasteur pipette.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Samples are then centrifuged at 1,200 × <Emphasis Type="Italic">g</Emphasis> for 30 min. It is important that slow deceleration is activated on the centrifuge to prevent mixing at the solution interface while the centrifuge is coming to a halt.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Following centrifugation, the mononuclear cell layer is aspirated from below the marrow/Ficoll interface and transferred to a fresh 50-ml tube (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec29_8">3</InternalRef>). The mononuclear cell layer will appear white and cloudy, and is most easily removed by passing a disposable plastic Pasteur pipette gently through the solution until the tip is just below the interface, and drawing up the mononuclear cell layer.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Add 30 ml of HBSS to the aspirate and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 10 min. Ficoll is toxic to cells, so it important to wash cells sufficiently to remove excess Ficoll.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the resulting pellet again in 30 ml of HBSS, and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the cell pellet in red blood cell lysis buffer at 4°C for 10 min, followed by centrifugation at 300 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>12.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the resultant pellet with 20 ml HBSS, and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>13.</ItemNumber>
                        <ItemContent>
                          <Para>Repeat <Emphasis Type="Bold">step 11</Emphasis>.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>14.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the final pellet in 1–5 ml of MSC growth medium (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec29_8">2</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>15.</ItemNumber>
                        <ItemContent>
                          <Para>Count the number of cells using a haemocytometer. Plate the cells at 1 × 10<Superscript>7</Superscript> cells per 25-cm<Superscript>2</Superscript> tissue culture flask in MSC growth media (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec29_8">4</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>16.</ItemNumber>
                        <ItemContent>
                          <Para>After 48 h replace media with fresh MSC growth medium to remove nonadherent cells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>17.</ItemNumber>
                        <ItemContent>
                          <Para>Media should then be replaced with fresh MSC growth medium every 3 days.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>18.</ItemNumber>
                        <ItemContent>
                          <Para>Cells should be confluent and ready for passage after 7–10 days (
                            <InternalRef RefID="Fig1">Fig. 1</InternalRef>
                            <Emphasis Type="Bold">a</Emphasis>).
<Figure Category="Standard" Float="Yes" ID="Fig1">
                              <Caption Language="En">
                                <CaptionNumber>Fig. 1.</CaptionNumber>
                                <CaptionContent>
                                  <SimplePara>Human MSCs under different culture conditions. Human MSCs grown to confluence in MSC growth medium display a flattened, fibroblast appearance under phase contrast (<Emphasis Type="Bold">a</Emphasis>). When cultured in neurosphere media containing EGF and bFGF, MSCs generate NSC-like neurospheres of different diameters (<Emphasis Type="Bold">b</Emphasis>). When cultured under conditions promoting neural differentiation, human MSCs express neural markers. Staining for βIII-tubulin identifies cells with a predominantly bipolar appearance and the presence of process-like extensions from the poles of the cell body (<Emphasis Type="Bold">c</Emphasis>; <Emphasis Type="Italic">arrows</Emphasis>). GFAP-labeled cells (<Emphasis Type="Italic">arrow</Emphasis>) exhibit intense staining throughout the cytoplasm and a predominantly flattened morphology (<Emphasis Type="Bold">d</Emphasis>). Scale bars 40 μm.</SimplePara>
                                </CaptionContent>
                              </Caption>
                              <MediaObject>
                                <ImageObject Color="BlackWhite" FileRef="MediaObjects/978-1-60327-931-4_8_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
                              </MediaObject>
                            </Figure>
                          </Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec12_8">
                  <Heading>MSC Passage</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove old MSC growth medium from flasks by aspiration, and rinse the cells with 2 × 10 ml of PBS to remove serum and cell debris.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>To dissociate adherent cells from the surface of the TC flask, either trypsin/EDTA or Accutase can be used. Depending on the size of the tissue culture flask, add the appropriate volume of trypsin/EDTA or Accutase solution. This is approximately 1 ml for a 25-cm<Superscript>2</Superscript> flask, 3 ml for a 75-cm<Superscript>2</Superscript> flask and 7 ml for a 175-cm<Superscript>2</Superscript> flask.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate the flasks at 37°C for 8 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>To ensure that all adherent cells have detached from the surface, the flask can be sharply tapped on a table surface several times to dislodge cells. Care must be taken not to splash media on the upper surface of the flask when doing this.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>The resulting cell suspension is transferred to a sterile 15-ml tube. If trypsin/EDTA is used to dissociate cells, add approximately 3× volume of a 15% solution of FBS in HBSS to inhibit trypsin. Accutase is self-digesting and therefore does not require the addition of an inhibitor solution.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge the suspension at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min in a bench top centrifuge.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the final pellet in 1 ml of MSC growth medium.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Count the number of MSCs using a haemocytometer and plate them at 1 × 10<Superscript>5</Superscript> cells per 25-cm<Superscript>2</Superscript> flask, 5 × 10<Superscript>5</Superscript> cells per 75-cm<Superscript>2</Superscript> flask or 1.2 × 10<Superscript>6</Superscript> cells per 175-cm<Superscript>2</Superscript> flask in MSC growth medium.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec13_8">
                  <Heading>Growth of MSCs on Coverslips</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Sterile 30-mm diameter round coverslips are placed into each well of a suitably sized tissue culture plate (4- or 24-well plate).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Add 500 μl of poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine solution and incubate at room temperature for a minimum of 30 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Excess poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine is removed and the coverslips dried in a 60°C drying oven overnight.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Passage MSCs as described until the final cell suspension is generated. Plate MSCs at approximately 1 × 10<Superscript>4</Superscript> cells per well in MSC growth media. Cells will be confluent 5–7 days after initial setup.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Fix cells by removing medium and adding 4% paraformaldehyde for 30 min at 37°C. Remove paraformaldehyde and rinse coverslips with several washed of PBS. Coverslips can be stored in PBS for several weeks prior to immunostaining if required.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec14_8">
                <Heading>Long-Term Storage of Human MSC Cultures</Heading>
                <Section3 ID="Sec15_8">
                  <Heading>Cryopreserving MSCs</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Passage MSCs as described to generate a single cell suspension and calculate the number of cells using a haemocytometer.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer a minimum of 1 × 10<Superscript>5</Superscript> cells to each cryotube</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>To each cryotube, slowly add 500 μl of prewarmed 50% MSC growth medium + 50% FBS. Gently mix the suspension.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>To each cryotube, add a further 500 μl of prewarmed MSC growth medium + 20% DMSO. Very gently mix the suspension to prevent any spillage.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Seal the cryotubes and transfer to a controlled-rate freezing container. The use of isopropanol in these containers results in a controlled freezing rate of 1°C/min, and prevents snap freezing which can damage cells (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Notes</Emphasis>
                            <InternalRef RefID="Sec29_8">5</InternalRef> and <InternalRef RefID="Sec29_8">6</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Place the controlled-rate freezing container into a −80°C freezer, and leave overnight.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Cryotubes can then be transferred to liquid nitrogen for long-term storage.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec16_8">
                  <Heading>Thawing Cryopreserved Cells</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Cryotubes are removed from liquid nitrogen and thawed in a waterbath at 37°C at least 10 min prior to use.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer 10 ml of prewarmed MSC growth medium to sterile 15-ml tubes. Label each tube to match a corresponding cryotube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>When the cryotubes are thawed, transfer them to the sterile biocabinet.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Using a 10-ml serological pipette, take up 3–4 ml of MSC growth medium from a 15-ml tube. Slowly mix the MSC growth medium and the thawed cell suspension, ensuring that all cells are rinsed from the tube. Care must be taken not to spill any medium, as this can lead to contamination.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer the 3–4 ml of medium, which now contains the thawed MSCs, into the medium that remains in the 15-ml tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>When all samples have been transferred from cryotubes into the appropriately-labeled 15-ml tubes, the samples are centrifuged at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min in a bench top centrifuge.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate the supernatant from each 15-ml tube, and resuspend each pellet in 10 ml of fresh MSC growth medium.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Again centrifuge the sample at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>After the second spin, each pellet is resuspended in 5 ml of MSC growth medium and transferred to a 25-cm<Superscript>2</Superscript> TC flask. Cells are then incubated and passaged as normal.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec17_8">
                <Heading>Confirming the Mesenchymal Origin of Human MSCs</Heading>
                <Para>An important consideration when working with MSCs is confirmation that such cells are indeed of mesenchymal origin. MSCs can be identified by flow cytometry by expression of a repertoire of surface receptors (either positive or negative surface expression depending on the marker) (<CitationRef CitationID="CR14_8">14</CitationRef>). Differentiating MSCs under conditions that induce cells to follow a specific developmental pathway (<CitationRef CitationID="CR14_8">14</CitationRef>) can also confirm their multilineage capacity. Following treatment, the ability of cells to appropriately differentiate can be examined by histochemical or immunocytochemical staining to detect the presence of suitable markers (<CitationRef CitationID="CR12_8">12</CitationRef>, <CitationRef CitationID="CR14_8">14</CitationRef>).</Para>
                <Section3 ID="Sec18_8">
                  <Heading>Flow Cytometry of Surface CD Markers</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Passage MSCs as described to generate a single cell suspension and calculate the number of cells using a haemocytometer.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Add 5% normal goat serum to the suspension to block cells. Incubate for 30 min at room temperature.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer a minimum of 5 × 10<Superscript>4</Superscript> cells to each sterile 15-ml centrifuge tube required. Add sufficient PBS to bring the volume to 1 ml.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Label the tubes as antibody, isotype control, secondary antibody alone, and cells alone.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Add the anti-CD marker primary antibody to the appropriately labeled tube and incubate for 1 h on ice in the dark (                            <InternalRef RefID="Tab1">Table 1</InternalRef>).
<Table Float="Yes" ID="Tab1">
                              <Caption Language="En">
                                <CaptionNumber>Table 1</CaptionNumber>
                                <CaptionContent>
                                  <SimplePara>Some common primary antibodies for human mesenchymal stem cell study</SimplePara>
                                </CaptionContent>
                              </Caption>
                              <tgroup cols="4">
                                <colspec colname="c0" colnum="0"/>
                                <colspec colname="c1" colnum="1"/>
                                <colspec colname="c2" colnum="2"/>
                                <colspec colname="c3" colnum="3"/>
                                <thead>
                                  <row>
                                    <entry colname="c0"/>
                                    <entry nameend="c3" namest="c1">
                                      <SimplePara>Antibody details</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Markers</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Isotype</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>Dilution</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Supplier (cat. no.)</SimplePara>
                                    </entry>
                                  </row>
                                </thead>
                                <tbody>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">MSC-expressed</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Fibronectin</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgM</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:400</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Sigma-Aldrich (F6140)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Vimentin</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgM</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:200</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Sigma-Aldrich (V5255)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">CD (surface)</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>CD44</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCA89XZ)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>CD45</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCAP87)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>CD90</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCAP90T)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>CD105</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCA1557)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>CD166</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCA1926GA)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">Adipogenic</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Lipoprotein lipase</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:200</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Abcam (Ab21356)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">Osteogenic</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Alkaline phosphatase</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:200</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Abcam (Ab17973)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">Chondrogenic</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Human Collagen II</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:200</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Chemicon (MAb1330)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>
                                        <Emphasis Type="Italic">Neurogenic</Emphasis>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c1"/>
                                    <entry colname="c2"/>
                                    <entry colname="c3"/>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Nestin</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:500</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Chemicon (MAb5326)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>βIII-tubulin</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Rabbit polyclonal</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:1000</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Sigma-Aldrich (T2200)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Glial fibrillary acidic protein (GFAP)</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgG<Subscript>1</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:500</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Chemicon (MAb360)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Oligodendrocyte marker O4</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Mouse IgM</SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:100</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>Chemicon (MAb345)</SimplePara>
                                    </entry>
                                  </row>
                                  <row>
                                    <entry colname="c0">
                                      <SimplePara>Myelin basic protein (MBP)</SimplePara>
                                    </entry>
                                    <entry colname="c1">
                                      <SimplePara>Rat IgG<Subscript>2a</Subscript>
                                      </SimplePara>
                                    </entry>
                                    <entry colname="c2">
                                      <SimplePara>1:10</SimplePara>
                                    </entry>
                                    <entry colname="c3">
                                      <SimplePara>AbD Serotec (MCA409S)</SimplePara>
                                    </entry>
                                  </row>
                                </tbody>
                              </tgroup>
                            </Table>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Add 10 ml of PBS to each tube, and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min to rinse cells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the pellets in 1 ml of PBS. Incubate the cells with secondary antibody or isotype control. The sample labeled cells alone gets neither. Incubate the cells for 1 h on ice in the dark.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Add 10 ml of PBS to each tube, and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min rinse cells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the cells in 1 ml of propidium iodide solution and incubate for 5 min on ice in the dark.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Add 10 ml of PBS to each tube, and centrifuge at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min rinse cells.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>11.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the pellets in 1 ml of PBS and transfer to FACS tubes. Store the samples on ice until ready to run through the flow cytometer. The cells alone, secondary antibody alone, and isotype control sample are all used to set initial flow cytometry gates, while propidium iodide is used to exclude all dead cells and debris.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec19_8">
                  <Heading>Adipogenic Induction</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are grown to confluence on poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine coated coverslips in MSC growth medium over 7–10 days.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Medium is removed from the wells, and cells rinsed with PBS × 2 to remove excess growth media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Add 500 μl of adipogenic <Emphasis Type="Italic">induction</Emphasis> medium to each well.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate the cell culture plates for 3 days.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Aspirate off the media, and add 500 μl of adipogenic <Emphasis Type="Italic">maintenance</Emphasis> medium to each well.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Addition of adipogenic induction and maintenance media is alternated every 3 days until the presence of lipid vacuoles are observed under the phase contrast microscope. It should take 14–21 days for this to occur.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Fix cells by removing medium and adding 4% paraformaldehyde for 30 min at 37°C. Remove paraformaldehyde and rinse coverslips with several washed of PBS. Coverslips can be stored in PBS for several weeks prior to histochemical staining for lipids or immunostaining (<Emphasis Type="Bold">Table</Emphasis>
                            <InternalRef RefID="Tab1">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec20_8">
                  <Heading>Osteogenic Induction</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are grown to confluence on poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine coated coverslips in MSC growth medium over 7–10 days. All incubations are carried out at 37°C/5% CO<Subscript>2</Subscript>.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Remove the old medium from the wells and rinse the cells and with PBS × 2 to remove excess growth media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Add 500 μl of osteogenic induction medium to each well.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Replace with fresh osteogenic induction medium every 3 days for 3–4 weeks.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Fix cells by removing medium and adding 4% paraformaldehyde for 30 min at 37°C. Remove paraformaldehyde and
rinse coverslips with several washed of PBS. Coverslips can be stored in PBS for several weeks prior to histochemical staining for bone markers or immunostaining (<Emphasis Type="Bold">Table</Emphasis>
                            <InternalRef RefID="Tab1">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec21_8">
                  <Heading>Chondrogenic Induction</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Following MSC passage and generation of a cell suspension, transfer 1.5 × 10<Superscript>5</Superscript> cells to a sterile 1.5-ml eppendorf tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge the cells at 300 × <Emphasis Type="Italic">g</Emphasis> for 8 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Remove the supernatant, and add 500 μl of chondrogenic induction medium</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Replace with fresh chondrogenic induction medium every 3 days for 3–4 weeks. The cells will form a pelletted micromass, so care must be taken when removing old medium that the pellet remains at the bottom of the tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>When ready, fix the pellet for 30 min in 4% paraformaldehyde.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>After several washes with PBS to remove excess fixative, cryo-protect the sample by submersion overnight in 0.5 M sucrose at 4°C.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Embed pellets in OCT compound in plastic moulds, and allow the blocks to set at −20°C.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Cut 12–20 μm thick sections in a cryostat containing a microtome. Mount the sections onto microscope slides and examine the sections for the presence of chondrogenic markers using histochemical staining for cartilage proteoglycans or immunostaining (<Emphasis Type="Bold">Table</Emphasis>
                            <InternalRef RefID="Tab1">1</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec22_8">
                <Heading>The Neurogenic Capacity of Cultured MSCs</Heading>
                <Section3 ID="Sec23_8">
                  <Heading>Generation of NSC-Like Neurospheres from Human MSCs</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>MSCs are harvested as normal from culture flasks during cell passage.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are plated down in low-attachment 12-well plates at 1 × 10<Superscript>4</Superscript> cells/well, or into low-attachment 75-cm<Superscript>2</Superscript> flasks at 5 × 10<Superscript>5</Superscript> cells/flask in neurosphere medium.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Cultures are incubated under normal conditions for 7–10 days. When cultures are ready, NSC-like neurospheres should range in size from 100 to 120 μm (<Emphasis Type="Bold">Fig.</Emphasis>
                            <InternalRef RefID="Fig1">1</InternalRef>
                            <Emphasis Type="Bold">b</Emphasis>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>When ready for passage, collect the NSC-like neurospheres by transferring the supernatant to a sterile 15-ml tube. Add 2 ml of prewarmed PBS or neurosphere medium to the flask to rinse out any remaining neurospheres, and add this to the medium already collected.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge the samples at 100 × <Emphasis Type="Italic">g</Emphasis> for 8 min in a bench top centrifuge. Discard the supernatant, and resuspend the pellet in 1 ml of either trypsin/EDTA or Accutase.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate the samples in a 37°C waterbath for 5 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>If trypsin/EDTA is used to dissociate cells, add approximately 3× volume of a 15% solution of FBS in HBSS to inhibit trypsin,
and mix well. Accutase is self-digesting and therefore does not require the addition of an inhibitor solution.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge samples at 100 × <Emphasis Type="Italic">g</Emphasis> for 8 min, and discard the supernatant.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the pellet in 1-ml of neurosphere medium, and gently triturated 5× through the tip of a Gilson P200 to generate a single-cell suspension.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Count the number of cells using a haemocytometer, and replate as described in <Emphasis Type="Bold">step 2</Emphasis>.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec24_8">
                  <Heading>Fixation of Intact NSC-Like Neurospheres</Heading>
                  <Para>It can be advantageous to immunostain intact NSC-like neurospheres, to examine the distribution of neural markers within the neurosphere.
<OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Collect NSC-like neurospheres by transferring the cell-suspension to a sterile 15-ml tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge the samples at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Discard the supernatant, and resuspend the spheres in 10 ml of PBS to wash off medium.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge the samples at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min, discard the supernatant and resuspend the pellet gently in 1 ml of 4% paraformaldehyde in PBS for 30 min at room temperature.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Rinse the neurospheres 3× with 10-ml washes of PBS, with centrifugation at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min between each wash.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>NSC-like neurospheres can be stored in PBS for several weeks prior to immunostaining.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec25_8">
                  <Heading>Neural Differentiation of MSCs on Coverslips</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Cells are harvested as normal from culture flasks during MSC- or NSC-like neurosphere passage, and plated at 1 × 10<Superscript>5</Superscript> cells/well onto poly-<Emphasis Type="SmallCaps">l</Emphasis>-lysine coated coverslips.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate the cells in neural induction medium containing either rh BDNF (which promotes neuronal differentiation) or rh PDGF-BB (promoting glial development).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>After 7–10 days fix cells by removing medium and adding 4% paraformaldehyde for 30 min at 37°C. Remove paraformaldehyde and rinse coverslips with several washes of PBS. Coverslips can be stored in PBS for several weeks prior to immunostaining if required.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec26_8">
                <Heading>Immunostaining</Heading>
                <Section3 ID="Sec27_8">
                  <Heading>Coverslip-Grown Cultures</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>If paraformaldehyde has been washed off previously, go to <Emphasis Type="Bold">step 2</Emphasis>. Otherwise rinse the coverslips with 3× washes of PBS, aspirating off PBS between washes.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Block and permeabilise cells with a solution of 4% normal goat serum and 0.1% Triton-X100 made up in PBS. Incubate the coverslips at 37° for 60 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the coverslips with 3× washes of PBS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Dilute the desired antibodies (<Emphasis Type="Bold">Table</Emphasis>
                            <InternalRef RefID="Tab1">1</InternalRef>) in blocking solution and incubate the coverslips for 60 min at room temperature, or 4°C overnight.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the coverslips with 3× washes of PBS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Dilute the secondary antibodies in blocking solution and incubate for 60 min at room temperature.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the coverslips with 3× washes of PBS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Mount the coverslips by inverting onto microscope slides using Vectashield mounting medium containing DAPI to visualise nuclei.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Visualise cells under a fluorescence-enabled microscope (<Emphasis Type="Bold">Fig.</Emphasis>
                            <InternalRef RefID="Fig1">1</InternalRef>
                            <Emphasis Type="Bold">c, d</Emphasis>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec28_8">
                  <Heading>NSC-Like Neurospheres in Suspension</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>If the paraformaldehyde has been washed off previously, go to <Emphasis Type="Bold">step 2</Emphasis>. Otherwise rinse the sphere suspensions with 2× washes of PBS, centrifuging at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min between each wash. All the steps in this protocol are carried out in 15-ml tubes.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Block and permeabilise spheres with a solution of 4% normal goat serum and 0.1% Triton-X100 made up in PBS. Incubate the spheres at 37° for 60 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the spheres with 2× washes of PBS, centrifuging at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min between each wash.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Dilute the desired antibodies (<Emphasis Type="Bold">Table</Emphasis>
                            <InternalRef RefID="Tab1">1</InternalRef>) in blocking solution and incubate the neurospheres for 60 min at room temperature. Ensure that a minimum of 500 μl of solution is used in each tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the spheres with 2× washes of PBS, centrifuging at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min between each wash.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Dilute the secondary antibodies in blocking solution and incubate the neurospheres for 60 min at room temperature. Ensure that a minimum of 500 μl of solution is used in each tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Wash the spheres with 2× washes of PBS, centrifuging at 100 × <Emphasis Type="Italic">g</Emphasis> for 10 min between each wash.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend the final pellet in 50 μl of Vectashield mounting medium containing DAPI to visualise nuclei.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Mount the spheres between spacers on a microscope slide. Do this by securing two coverslips to a slide, with a space of approximately half a coverslip length between them. Place the sphere suspension onto the slide between the spacers, and place a final coverslip on top. Seal with nail polish.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Visualise NSC-like neurospheres under a fluorescence-enabled microscope.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
            </Section1>
            <Section1 ID="Sec29_8">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>The handling of all human bone marrow and marrow-derived cultures should be carried out in a Class 2 bio-cabinet or laminar flow cabinet. Sterilise equipment by autoclaving or by spraying with 70% ethanol.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>MSC growth medium should be sterilised through 0.22-μm pore size filter units.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>Aspiration of media from flasks and tubes should be carried out using sterile glass Pasteur pipettes attached to a vacuum pump and waste collector (containing bleach or similarly appropriate lab disinfectant).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>All cells are cultured or differentiated at 37°C/5% CO<Subscript>2</Subscript> in a humidified atmosphere.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>Up to 1 × 10<Superscript>6</Superscript> cells can be frozen per cryotube. A higher number of cells per 25-cm<Superscript>2</Superscript> TC flask after thawing will mean that cells are confluent faster and those cultures can be restocked quicker if needed.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para>Freezing NSC-like neurospheres follows the same protocol as described above for MSC cultures. Collect the neurospheres 3–4 days after they have been passaged into low-attachment TC plates or flasks for freezing.</Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_8.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Bibliography ID="Bib1_8">
              <Heading>References</Heading>
              <Citation ID="CR1_8">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Bjorklund</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Cell replacement strategies for neurodegenerative disorders</ArticleTitle>
                  <JournalTitle>Novartis Found Symp</JournalTitle>
                  <VolumeID>231</VolumeID>
                  <FirstPage>7</FirstPage>
                  <LastPage>15</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11131546</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/0470870834.ch2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M7jsleitw%3D%3D</Handle>
                  </Occurrence>
                  <BibComments>discussion 16–20</BibComments>
                </BibArticle>
                <BibUnstructured>Bjorklund, A. (2000) Cell replacement strategies for neurodegenerative disorders. Novartis Found Symp 231: 7–15; discussion 16–20.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_8">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Q.</Initials>
                    <FamilyName>Cao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R. L.</Initials>
                    <FamilyName>Benton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. R.</Initials>
                    <FamilyName>Whittemore</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Stem cell repair of central nervous system injury</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>68</VolumeID>
                  <FirstPage>501</FirstPage>
                  <LastPage>510</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12111840</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10240</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xks1Kquro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cao, Q., Benton, R. L. &amp; Whittemore, S. R. (2002) Stem cell repair of central nervous system injury. J Neurosci Res 68: 501–510.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_8">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K. I.</Initials>
                    <FamilyName>Park</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Ourednik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Ourednik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R. M.</Initials>
                    <FamilyName>Taylor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K. S.</Initials>
                    <FamilyName>Aboody</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K. I.</Initials>
                    <FamilyName>Auguste</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. B.</Initials>
                    <FamilyName>Lachyankar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. E.</Initials>
                    <FamilyName>Redmond</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E. Y.</Initials>
                    <FamilyName>Snyder</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Global gene and cell replacement strategies via stem cells</ArticleTitle>
                  <JournalTitle>Gene Ther</JournalTitle>
                  <VolumeID>9</VolumeID>
                  <FirstPage>613</FirstPage>
                  <LastPage>624</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12032707</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/sj.gt.3301721</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XjslSht70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Park, K. I., Ourednik, J., Ourednik, V., Taylor, R. M., Aboody, K. S., Auguste, K. I., Lachyankar, M. B., Redmond, D. E. &amp; Snyder, E. Y. (2002) Global gene and cell replacement strategies via stem cells. Gene Ther 9: 613–624.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_8">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>I. L.</Initials>
                    <FamilyName>Weissman</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Translating stem and progenitor cell biology to the clinic: barriers and opportunities</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>287</VolumeID>
                  <FirstPage>1442</FirstPage>
                  <LastPage>1446</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10688785</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.287.5457.1442</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXhsV2qtrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Weissman, I. L. (2000) Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287: 1442–1446.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_8">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Clarke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Frisen</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Differentiation potential of adult stem cells</ArticleTitle>
                  <JournalTitle>Curr Opin Genet Dev</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>575</FirstPage>
                  <LastPage>580</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11532401</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0959-437X(00)00235-5</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmt1Krt7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Clarke, D. &amp; Frisen, J. (2001) Differentiation potential of adult stem cells. Curr Opin Genet Dev 11: 575–580.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_8">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Poulsom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. R.</Initials>
                    <FamilyName>Alison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. J.</Initials>
                    <FamilyName>Forbes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N. A.</Initials>
                    <FamilyName>Wright</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Adult stem cell plasticity</ArticleTitle>
                  <JournalTitle>J Pathol</JournalTitle>
                  <VolumeID>197</VolumeID>
                  <FirstPage>441</FirstPage>
                  <LastPage>456</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12115861</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/path.1176</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Poulsom, R., Alison, M. R., Forbes, S. J. &amp; Wright, N. A. (2002) Adult stem cell plasticity. J Pathol 197: 441–456.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_8">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Serafini</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C. M.</Initials>
                    <FamilyName>Verfaillie</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Pluripotency in adult stem cells: state of the art</ArticleTitle>
                  <JournalTitle>Semin Reprod Med</JournalTitle>
                  <VolumeID>24</VolumeID>
                  <FirstPage>379</FirstPage>
                  <LastPage>388</LastPage>
                  <Occurrence Type="PID">
                    <Handle>17123233</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1055/s-2006-952153</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2sXisVSksw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Serafini, M. &amp; Verfaillie, C. M. (2006) Pluripotency in adult stem cells: state of the art. Semin Reprod Med 24: 379–388.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S. L.</Initials>
                    <FamilyName>Preston</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. R.</Initials>
                    <FamilyName>Alison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. J.</Initials>
                    <FamilyName>Forbes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N. C.</Initials>
                    <FamilyName>Direkze</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Poulsom</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N. A.</Initials>
                    <FamilyName>Wright</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">The new stem cell biology: something for everyone</ArticleTitle>
                  <JournalTitle>Mol Pathol</JournalTitle>
                  <VolumeID>56</VolumeID>
                  <FirstPage>86</FirstPage>
                  <LastPage>96</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12665626</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1136/mp.56.2.86</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3s7nvFymsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Preston, S. L., Alison, M. R., Forbes, S. J., Direkze, N. C., Poulsom, R. &amp; Wright, N. A. (2003) The new stem cell biology: something for everyone. Mol Pathol 56: 86–96.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_8">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D. J.</Initials>
                    <FamilyName>Prockop</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Adult stem cells gradually come of age</ArticleTitle>
                  <JournalTitle>Nat Biotechnol</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>791</FirstPage>
                  <LastPage>792</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12148006</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nbt0802-791</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xls1Cmtbs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Prockop, D. J. (2002) Adult stem cells gradually come of age. Nat Biotechnol 20: 791–792.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_8">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Scolding</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">New cells from old</ArticleTitle>
                  <JournalTitle>Lancet</JournalTitle>
                  <VolumeID>357</VolumeID>
                  <FirstPage>329</FirstPage>
                  <LastPage>330</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11210992</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0140-6736(00)03637-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3M7is1yjtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Scolding, N. (2001) New cells from old. Lancet 357: 329–330.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_8">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Treatment of neural injury with marrow stromal cells</ArticleTitle>
                  <JournalTitle>Lancet Neurol</JournalTitle>
                  <VolumeID>1</VolumeID>
                  <FirstPage>92</FirstPage>
                  <LastPage>100</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12849513</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S1474-4422(02)00040-6</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chopp, M. &amp; Li, Y. (2002) Treatment of neural injury with marrow stromal cells. Lancet Neurol 1: 92–100.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_8">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B. N.</Initials>
                    <FamilyName>Jahagirdar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R. L.</Initials>
                    <FamilyName>Reinhardt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R. E.</Initials>
                    <FamilyName>Schwartz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C. D.</Initials>
                    <FamilyName>Keene</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>X. R.</Initials>
                    <FamilyName>Ortiz-Gonzalez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Reyes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Lenvik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Lund</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Pluripotency of mesenchymal stem cells derived from adult marrow</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>418</VolumeID>
                  <FirstPage>41</FirstPage>
                  <LastPage>49</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12077603</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/nature00870</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XltVantrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., Schwartz, R. E., Keene, C. D., Ortiz-Gonzalez, X. R., Reyes M., Lenvik, T., Lund, T., et al (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41–49.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_8">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D. S.</Initials>
                    <FamilyName>Krause</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N. D.</Initials>
                    <FamilyName>Theise</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. I.</Initials>
                    <FamilyName>Collector</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.</Initials>
                    <FamilyName>Henegariu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Hwang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Gardner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Neutzel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. J.</Initials>
                    <FamilyName>Sharkis</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell</ArticleTitle>
                  <JournalTitle>Cell</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>369</FirstPage>
                  <LastPage>377</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11348593</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0092-8674(01)00328-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjs1aitrY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Krause, D. S., Theise, N. D., Collector, M. I., Henegariu, O., Hwang, S., Gardner, R., Neutzel S. &amp; Sharkis, S. J. (2001) Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 105: 369–377.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_8">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M. F.</Initials>
                    <FamilyName>Pittenger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A. M.</Initials>
                    <FamilyName>Mackay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S. C.</Initials>
                    <FamilyName>Beck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R. K.</Initials>
                    <FamilyName>Jaiswal</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Douglas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. D.</Initials>
                    <FamilyName>Mosca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. A.</Initials>
                    <FamilyName>Moorman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. W.</Initials>
                    <FamilyName>Simonetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Craig</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. R.</Initials>
                    <FamilyName>Marshak</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Multilineage potential of adult human mesenchymal stem cells</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>284</VolumeID>
                  <FirstPage>143</FirstPage>
                  <LastPage>147</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10102814</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.284.5411.143</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXitlCnu7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig S. &amp; Marshak, D. R. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143–147.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_8">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Deng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Obrocka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.</Initials>
                    <FamilyName>Fischer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. J.</Initials>
                    <FamilyName>Prockop</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP</ArticleTitle>
                  <JournalTitle>Biochem Biophys Res Commun</JournalTitle>
                  <VolumeID>282</VolumeID>
                  <FirstPage>148</FirstPage>
                  <LastPage>152</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11263984</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/bbrc.2001.4570</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitFeitLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Deng, W., Obrocka, M., Fischer, I. &amp; Prockop, D. J. (2001) In vitro differentiation of human marrow stromal cells into early progenitors of neural cells by conditions that increase intracellular cyclic AMP. Biochem Biophys Res Commun 282: 148–152.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_8">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>B. J.</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. H.</Initials>
                    <FamilyName>Seo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. K.</Initials>
                    <FamilyName>Bubien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y. S.</Initials>
                    <FamilyName>Oh</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro</ArticleTitle>
                  <JournalTitle>Neuroreport</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>1185</FirstPage>
                  <LastPage>1188</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12151766</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1097/00001756-200207020-00023</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kim, B. J., Seo, J. H., Bubien, J. K. &amp; Oh, Y. S. (2002) Differentiation of adult bone marrow stem cells into neuroprogenitor cells in vitro. Neuroreport 13: 1185–1188.</BibUnstructured>
              </Citation>
              <Citation ID="CR17_8">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Cardozo-Pelaez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Hazzi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Stedeford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T. B.</Initials>
                    <FamilyName>Freeman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Saporta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Janssen</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Adult bone marrow stromal cells differentiate into neural cells in vitro</ArticleTitle>
                  <JournalTitle>Exp Neurol</JournalTitle>
                  <VolumeID>164</VolumeID>
                  <FirstPage>247</FirstPage>
                  <LastPage>256</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10915564</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/exnr.2000.7389</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXltFemsr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., Freeman, T. B., Saporta S., Janssen, W., et al (2000) Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol 164: 247–256.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_8">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Woodbury</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E. J.</Initials>
                    <FamilyName>Schwarz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. J.</Initials>
                    <FamilyName>Prockop</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I. B.</Initials>
                    <FamilyName>Black</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Adult rat and human bone marrow stromal cells differentiate into neurons</ArticleTitle>
                  <JournalTitle>J Neurosci Res</JournalTitle>
                  <VolumeID>61</VolumeID>
                  <FirstPage>364</FirstPage>
                  <LastPage>370</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10931522</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/1097-4547(20000815)61:4&lt;364::AID-JNR2&gt;3.0.CO;2-C</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXlsFCrt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Woodbury, D., Schwarz, E. J., Prockop, D. J. &amp; Black, I. B. (2000) Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res 61: 364–370.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_8">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Hermann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Gastl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Liebau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M. O.</Initials>
                    <FamilyName>Popa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Fiedler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B. O.</Initials>
                    <FamilyName>Boehm</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Maisel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Lerche</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Schwarz</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells</ArticleTitle>
                  <JournalTitle>J Cell Sci</JournalTitle>
                  <VolumeID>117</VolumeID>
                  <FirstPage>4411</FirstPage>
                  <LastPage>4422</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15304527</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1242/jcs.01307</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXovVehtr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hermann, A., Gastl, R., Liebau, S., Popa, M. O., Fiedler, J., Boehm, B. O., Maisel, M., Lerche H., Schwarz J., et al (2004) Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 117: 4411–4422.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_8">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Akiyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Radtke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.</Initials>
                    <FamilyName>Honmou</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. D.</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Remyelination of the spinal cord following intravenous delivery of bone marrow cells</ArticleTitle>
                  <JournalTitle>Glia</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <FirstPage>229</FirstPage>
                  <LastPage>236</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12203389</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/glia.10102</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akiyama, Y., Radtke, C., Honmou, O. &amp; Kocsis, J. D. (2002) Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia 39: 229–236.</BibUnstructured>
              </Citation>
              <Citation ID="CR21_8">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Akiyama</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Radtke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J. D.</Initials>
                    <FamilyName>Kocsis</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells</ArticleTitle>
                  <JournalTitle>J Neurosci</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <FirstPage>6623</FirstPage>
                  <LastPage>6630</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12151541</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XlvFKntr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Akiyama, Y., Radtke, C. &amp; Kocsis, J. D. (2002) Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci 22: 6623–6630.</BibUnstructured>
              </Citation>
              <Citation ID="CR22_8">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S. A.</Initials>
                    <FamilyName>Azizi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Stokes</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B. J.</Initials>
                    <FamilyName>Augelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>DiGirolamo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D. J.</Initials>
                    <FamilyName>Prockop</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>95</VolumeID>
                  <FirstPage>3908</FirstPage>
                  <LastPage>3913</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9520466</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.95.7.3908</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXitlKjuro%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Azizi, S. A., Stokes, D., Augelli, B. J., DiGirolamo, C. &amp; Prockop, D. J. (1998) Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats – similarities to astrocyte grafts. Proc Natl Acad Sci USA 95: 3908–3913.</BibUnstructured>
              </Citation>
              <Citation ID="CR23_8">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T. R.</Initials>
                    <FamilyName>Brazelton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F. M.</Initials>
                    <FamilyName>Rossi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G. I.</Initials>
                    <FamilyName>Keshet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H. M.</Initials>
                    <FamilyName>Blau</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">From marrow to brain: expression of neuronal phenotypes in adult mice</ArticleTitle>
                  <JournalTitle>Science</JournalTitle>
                  <VolumeID>290</VolumeID>
                  <FirstPage>1775</FirstPage>
                  <LastPage>1779</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11099418</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1126/science.290.5497.1775</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXovVOhurc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Brazelton, T. R., Rossi, F. M., Keshet, G. I. &amp; Blau, H. M. (2000) From marrow to brain: expression of neuronal phenotypes in adult mice. Science 290: 1775–1779.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>